Your browser doesn't support javascript.
loading
Development of secondary urothelial carcinoma following complete response to immune checkpoint inhibitors.
Lavoie, Jean-Michel; Vandekerkhove, Gillian; Murtha, Andrew J; Wang, Gang; Wyatt, Alexander W; Eigl, Bernhard J.
Afiliação
  • Lavoie JM; Department of Medical Oncology, BC Cancer - Surrey, Surrey, Canada.
  • Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Murtha AJ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Wang G; Department of Pathology and Laboratory Medicine, BC Cancer - Vancouver, Vancouver, Canada.
  • Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.
  • Eigl BJ; Department of Medical Oncology, BC Cancer - Vancouver, Vancouver, Canada.
Urol Case Rep ; 39: 101762, 2021 Nov.
Article em En | MEDLINE | ID: mdl-34258232
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article